Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02655601
Title Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors BioMimetix JV, LLC
Indications

high grade glioma

Therapies

BMX-001 + Temozolomide

Temozolomide

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.